Subglottic Secretion Culture in Predicting Tracheal Microbial Flora
Value of Subglottic Secretion Culture in Predicting Microbial Flora of Tracheal Secretions in Intubated Patients. a Prospective Observational Study
1 other identifier
observational
100
1 country
1
Brief Summary
Ventilator-associated pneumonia (VAP) continues to be a major cause of morbidity and mortality in the intensive care unit (ICU). Microaspiration of subglottic secretions accumulated above the endotracheal tube cuff is the primary route of bacterial entry into the lower respiratory tract.Therefore, removal of secretions from the subglottic spacehas been recommended as a preventive strategy to avoid microaspiration and VAP. In this context, whereas considerable literature exists on the use subglottic secretion drainage (SSD) in patients at risk for developing VAP, there is a lack of data on the bacterial growth in the subglottic fluid above the cuff. The primary objective of the study will be to assess the value of subglottic secretion culture in predicting microbial flora of endotracheal aspirate samplein patients admitted to our ICU and under invasive mechanical ventilation for at least 48 hours. Secondary end-point will be to estimate the predictive value of subglottic secretion culture in identifying bacterial pathogens in the sub-population of patients who will develop VAP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2017
CompletedFirst Posted
Study publicly available on registry
May 15, 2017
CompletedStudy Start
First participant enrolled
October 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2018
CompletedSeptember 25, 2024
July 1, 2019
1 year
April 29, 2017
September 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients with the same pathogens in both subglottic secretions and endotracheal aspirates
6 months
Interventions
No intervention
Eligibility Criteria
ICU patients under invasive mechanica ventilations for at least 48 hours
You may qualify if:
- ≥18 years of age
- Invasive mechanical ventilation for at least 48 hours
You may not qualify if:
- age \<18 years
- absence of informed consent
- pregnancy
- documented treatment-limitation orders in the patient's chart
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazioen Policlinico Universitario A. Gemelli IRCCS
Roma, 00168, Italy
Related Publications (1)
Bello G, Bisanti A, Giammatteo V, Montini L, Eleuteri D, Fiori B, La Sorda M, Spanu T, Grieco DL, Pennisi MA, De Pascale G, Antonelli M. Microbiologic surveillance through subglottic secretion cultures during invasive mechanical ventilation: a prospective observational study. J Crit Care. 2020 Oct;59:42-48. doi: 10.1016/j.jcrc.2020.05.013. Epub 2020 May 26.
PMID: 32516641DERIVED
Biospecimen
subglottic secretions and tracheal aspirates
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Giuseppe Bello (Principal-Investigator)
Study Record Dates
First Submitted
April 29, 2017
First Posted
May 15, 2017
Study Start
October 20, 2017
Primary Completion
October 20, 2018
Study Completion
November 20, 2018
Last Updated
September 25, 2024
Record last verified: 2019-07